It is worth noting that MBD2 is involved in the differentiation and expression of Th17 and its asthma-related inflammatory cytokines via inducing epigenetic changes through different mechanisms, and MBD2 itself and/or MBD2 mediated Th 17 cells can be a potential therapeutic target in severe asthma. Here, MBD2 is linked to asthma.